Hip and knee implants are a big market -- according to Smith & Nephew's (NYSE:SNN) 2013 annual report, worth $14 billion last year. And given that the market has seen strong growth, with Medicare-covered knee replacement surgeries growing by 162% from 1991 to 2010, it's time to consider what investments might be most attractive in this market -- particularly given that most of them pay a dividend. So, Smith & Nephew? Zimmer (UNKNOWN:ZMH.DL)? Stryker (NYSE:SYK)? Johnson & Johnson (NYSE:JNJ)?

In the video below, Motley Fool health care analysts Michael Douglass and David Williamson give their take.